Recro Pharma

REPH

Sector
Healthcare

Industry
Biotechnology

Website
recropharma.com




Buy / Sell (dollars)

1 Month

34.1% 34.1% Complete (success)
65.9% 65.9% Complete (danger)
$665,045.00
avg. $665,045.00
$1.287M
avg. $1.287M

Buy/Sell Ratio

0.517

Transactions

12

Filers

9

3 Month

34.1% 34.1% Complete (success)
65.9% 65.9% Complete (danger)
$665,045.00
avg. $221,681.67
$1.287M
avg. $429,098.50

Buy/Sell Ratio

0.517

Transactions

12

Filers

9

12 Month

30.9% 30.9% Complete (success)
69.1% 69.1% Complete (danger)
$640,395.00
avg. $53,366.25
$1.429M
avg. $119,085.99

Buy/Sell Ratio

0.448

Transactions

32

Filers

11

24 Month

5.6% 5.6% Complete (success)
94.4% 94.4% Complete (danger)
$471,227.00
avg. $19,634.46
$7.937M
avg. $330,687.65

Buy/Sell Ratio

0.059

Transactions

105

Filers

20

Recent Filings - SEC Form 4


CFO Buys & Sells

The following shows events open market buys and sells made by CFOs. The CFO is likely to be the best person within a company to watch for insider signals.
On the right you can see the maximum upside and downside produced in the 7 months after the filing was made and how long it took to arrive.
These values are updated daily.

CFO data is restricted to data over 5 years old.
You need a free account to see up-to-date data.
Log in to get free access to this feature and more.



Filers